MyDrHank vs Tell Her Doc
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Readers who intend to pay for a full year up front and will do the arithmetic first — at the month-to-month rate this is one of the more expensive compounded sellers we cover.
- semaglutide
- $259/mo
- tirzepatide
- $349/mo
Before enrolling
Every advertised price is an annual-prepay minimum. The site's own code takes the cheapest rung of a four-term ladder and prints it as “From $X/mo”, so the $240/mo tirzepatide, $178/mo injectable semaglutide and $171/mo oral semaglutide it markets are what $2,883, $2,140 and $2,057 paid up front work out to per month — the month-to-month rates, $349, $259 and $249, are displayed nowhere, and the FAQ still calls the prepay figure a plan with “no contract”
Desk Score
Women-focused compounded semaglutide or tirzepatide in injection, oral or ODT form with a named pharmacy.
- semaglutide
- From $269/molowest dose rung
- tirzepatide
- Not confirmed for Tell Her Doc.
Before enrolling
'All sales are final' — no refunds once medication has left the pharmacy
Our review of Tell Her Doc gives it 74/100 (C), while our review of MyDrHank gives it 73/100 (C). The score breakdown shows where each provider does better.
Desk Score, dimension by dimension
Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.
73/100
C
74/100
C
The spec sheet
Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.
| Field | MyDrHank | Tell Her Doc |
|---|---|---|
| Semaglutide | $259/moFull plan terms$259/mo month-to-month (compounded injectable; oral $249/mo; the injection's advertised $178/mo is a $2,140 annual prepay, and the $171/mo on its sign-up pages is the oral tablet's $2,057 annual prepay) | From $269/molowest dose rungFull plan terms$269/mo (microdose tier, plus a separate fee, compounded) |
| Tirzepatide | $349/moFull plan terms$349/mo month-to-month (compounded; the advertised $240/mo is a $2,883 annual prepay) | Not confirmed for Tell Her Doc. |
| Coverage | 44 states (excludes Kansas, Louisiana, Mississippi, New Mexico, North Dakota, West Virginia) | All 50 states |
| Brand-name | Not confirmed here | Not confirmed here |
| Oral option | Oral option listed | Oral option listed |
| Best for | Readers who intend to pay for a full year up front and will do the arithmetic first — at the month-to-month rate this is one of the more expensive compounded sellers we cover. | Women-focused compounded semaglutide or tirzepatide in injection, oral or ODT form with a named pharmacy. |
| Desk Score | 73/100C | 74/100C |
The verdict
Desk pick — Tell Her DocTell Her Doc has the higher Desk Score, but MyDrHank may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.
Readers who intend to pay for a full year up front and will do the arithmetic first — at the month-to-month rate this is one of the more expensive compounded sellers we cover.
Women-focused compounded semaglutide or tirzepatide in injection, oral or ODT form with a named pharmacy.
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.
More head-to-heads
- CoreAge Rx vs MyDrHank
- CoreAge Rx vs Tell Her Doc
- MyDrHank vs Strut Health
- Nolu vs Tell Her Doc
- MyDrHank vs Ondra Health
- Clume Health vs Tell Her Doc
Or see the full comparison hub and the complete ranking.